Intas Intagesic-mr Tablet for Dogs and Cats, 10 Tablets

Simultaneous Multi-Mechanism Pain Relief:
Intagesic MR Tablet's triple-active formulation attacks musculoskeletal pain through three distinct and complementary pharmacological pathways: peripheral prostaglandin blockade by Diclofenac, central pain processing modulation by Paracetamol, and spinal reflex-mediated muscle spasm suppression by Chlorzoxazone. This convergent targeting of pain at its peripheral origin, central amplification pathway, and musculoskeletal component delivers a faster and more complete analgesic effect than any single drug alone, alleviating discomfort more efficiently with a lower cumulative NSAID burden.

Rapid Onset of Musculoskeletal Pain Control:
The onset of pain relief with Intagesic MR Tablet is typically observed within thirty minutes to one hour of oral administration, driven by Diclofenac's rapid gastrointestinal absorption and Paracetamol's swift central action. This rapid pain control is particularly valuable in acute conditions such as sports injuries, lumbar strain, post-operative pain, and traumatic soft tissue injury, where timely analgesic intervention supports patient comfort, reduces anxiety, and facilitates earlier mobilisation and rehabilitation.

Targeted Relief of Muscle Spasm and Stiffness:
The inclusion of Chlorzoxazone as a centrally acting muscle relaxant specifically addresses the component of musculoskeletal pain that peripheral NSAIDs alone cannot resolve: involuntary muscle spasm and guarding. By relieving reflex-driven spasm at the spinal cord level, Intagesic MR restores muscle pliability, reduces secondary ischaemic pain within cramped muscle fibres, and enables patients to engage in prescribed physiotherapy and mobilisation exercises that are essential to full recovery.

Anti-Inflammatory and Oedema Reduction:
Diclofenac's COX inhibition reduces the local production of prostaglandins and prostacyclin at injured tissue sites, directly diminishing vascular hyperpermeability and fluid exudation into the interstitium. This anti-oedema effect reduces tissue swelling, the associated pressure on local nociceptors, and post-surgical fluid accumulation, reinforcing comfort and supporting faster tissue healing in the acute inflammatory phase.

Synergistic Analgesic Formulation Improves Overall Tolerability:
Because Paracetamol's central analgesic action potentiates Diclofenac's peripheral effect, the 50 mg Diclofenac dose in Intagesic MR is lower than typical standalone Diclofenac prescriptions, reducing gastrointestinal mucosal exposure and the prostaglandin-mediated disruption of gastric cytoprotection. This formulation strategy targets a more favourable tolerability profile for short-term use compared to higher-dose single NSAID regimens, while maintaining equivalent or superior analgesic efficacy.

How to Use:

Intagesic MR Tablet must only be taken as directed by a qualified medical professional. The tablet should be swallowed whole with a full glass of water; do not crush, break, or chew it as this may alter the drug release profile and increase the risk of gastrointestinal irritation.

Storage Advice:

Store unopened Intagesic MR Tablets in a cool, dry place below 25 degrees Celsius, away from direct sunlight, heat, and humidity. Do not freeze. Once the strip is opened, store remaining tablets in the same conditions and in their original blister packaging to protect them from moisture. Keep this medicine out of reach of children at all times. Do not use after the expiry date printed on the strip and carton.

About the Brand:

Intas Pharmaceuticals Ltd. was founded in 1977 by Hasmukh Chudgar in Ahmedabad, India, and has grown from a single domestic enterprise into one of India's largest privately owned pharmaceutical companies, currently ranked among the top ten in the Indian pharmaceutical market with a presence in more than 85 countries across North America, Europe, Asia-Pacific, Latin America, CIS, and MENA regions. The company holds manufacturing accreditations from the world's most rigorous regulatory authorities including USFDA, EMA (EU-GMP certification, the first Indian company to receive it for biosimilars), MHRA, TGA, and WHO-GMP, and operates 17 advanced formulation, R&D, and distribution facilities globally. Intas invests approximately six to seven percent of its revenues in research and development, employing over 800 scientists and maintaining a strategic pipeline of more than 300 high-value products including biosimilars, novel drug delivery systems, and first-to-file generics across oncology, cardiovascular, central nervous system, gastroenterology, and pain management therapeutic areas. Intas's unwavering commitment to making high-quality, affordable pharmaceutical formulations accessible across regulated and emerging markets alike aligns with Animeal's commitment to offering only rigorously validated, medically credible healthcare products for every patient and pet family. Discover Intas Pharmaceuticals today.

Disclaimer:

Please note that while Intagesic MR Tablet is formulated from Chlorzoxazone (250 mg), Diclofenac Sodium (50 mg), and Paracetamol (325 mg), and is appropriate for adults with acute musculoskeletal pain and associated muscle spasm, it is a Schedule H prescription medicine and must not be purchased, dispensed, or self-administered without a valid prescription from a registered medical practitioner. It is not a substitute for appropriate medical diagnosis, physiotherapy, or prescribed rehabilitation. This product is contraindicated in pregnancy, breastfeeding, children, and individuals with active peptic ulcers, significant liver or renal impairment, severe cardiovascular disease, a history of hypersensitivity to NSAIDs or paracetamol, or nasal polyps. Long-term use without medical supervision carries significant risks of gastrointestinal bleeding, hepatic stress, and renal impairment. For patients with asthma, hypertension, diabetes, or those on anticoagulants, diuretics, lithium, or methotrexate therapy, consult your physician before initiating this product. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.